Literature DB >> 6318664

Oral antiviral drugs in experimental herpes simplex keratitis.

H E Kaufman, E D Varnell, Y M Centifanto-Fitzgerald, E De Clercq, G E Kissling.   

Abstract

Chronic oral administration of acyclovir or bromovinyl deoxyuridine to rabbits did not prevent recurrence of virus shedding or clinical corneal disease, nor did it alter the clinical course of recurrences of ocular herpetic disease or result in the appearance of resistant virus in tears.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6318664      PMCID： PMC185402          DOI： 10.1128/AAC.24.6.888

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers.

Authors:  P C Wellings; P N Awdry; F H Bors; B R Jones; D C Brown; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1972-06       Impact factor: 5.258

2.  Herpes simplex keratitis.

Authors:  H E Kaufman; Y M Centifanto-Fitzgerald; E D Varnell
Journal:  Ophthalmology       Date:  1983-06       Impact factor: 12.079

3.  Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes.

Authors:  A E Nilsen; T Aasen; A M Halsos; B R Kinge; E A Tjøtta; K Wikström; A P Fiddian
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

4.  Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.

Authors:  E de Clercq; Z X Zhang; I S Sim
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Human leukocyte interferon for the prevention of recurrences of herpetic keratitis.

Authors:  H E Kaufman; R F Meyer; P R Laibson; S R Waltman; A B Nesburn; J J Shuster
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

6.  Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy.

Authors:  H J Field
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

7.  THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS.

Authors:  H E KAUFMAN; C HEIDELBERGER
Journal:  Science       Date:  1964-08-07       Impact factor: 47.728

8.  Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease.

Authors:  J J Shuster; H E Kaufman; A B Nesburn
Journal:  Am J Ophthalmol       Date:  1981-03       Impact factor: 5.258

9.  Effect of intensive acyclovir therapy during artificial reactivation of latent herpes simplex virus.

Authors:  A B Nesburn; D E Willey; M D Trousdale
Journal:  Proc Soc Exp Biol Med       Date:  1983-03
  9 in total
  4 in total

Review 1.  Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.

Authors:  D Pavan-Langston
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.

Authors:  W G Liu; Z J Chen; J Z Song; Z X Ma
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

3.  Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.

Authors:  J M Loutsch; B Sainz; M E Marquart; X Zheng; P Kesavan; S Higaki; J M Hill; R Tal-Singer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.

Authors:  P A Asbell
Journal:  Trans Am Ophthalmol Soc       Date:  2000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.